Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2019 08:30 ET | Source: Avedro, Inc

Avedro, Inc. Announces Third Quarter 2019 Financial Results

WALTHAM, Mass., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (Avedro), today reported financial results for the quarter ended September 30, 2019. Third Quarter Financial...
October 09, 2019 16:30 ET | Source: Avedro, Inc

Avedro Announces Schedule of Events at the American Academy of Ophthalmology Annual Meeting

WALTHAM, Mass., Oct. 09, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (Avedro) today announced its schedule of scientific and educational programs focused on corneal cross-linking and...
September 11, 2019 16:30 ET | Source: Avedro, Inc

Boost Epi-On™ Corneal Cross-Linking Data to Be Presented at the 37th Congress of the ESCRS

WALTHAM, Mass., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (Avedro), today announced the inclusion of a wide array of Boost Epi-On cross-linking (CXL) presentations in the...
August 07, 2019 16:15 ET | Source: Avedro, Inc

Avedro, Inc. Announces Second Quarter 2019 Financial Results

Updates Full Year 2019 Revenue Guidance Earnings Call and Webcast Previously Scheduled for Tomorrow, Thursday, August 8 Will Now Occur Today, Wednesday, August 7 at 4:30 p.m. ET as a joint call with...
July 25, 2019 16:05 ET | Source: Avedro, Inc

Avedro, Inc. to Report Second Quarter 2019 Financial Results on August 8, 2019

WALTHAM, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), today announced that it will release financial results for the second quarter of 2019 after the close of...
May 20, 2019 16:05 ET | Source: Avedro, Inc

Avedro, Inc. to Present at the Guggenheim MedTech Disruptors Summit

WALTHAM, Mass., May 20, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), today announced the company will be participating in the upcoming Guggenheim MedTech Disruptors Summit in New...
May 09, 2019 16:05 ET | Source: Avedro, Inc

Avedro, Inc. Announces First Quarter 2019 Financial Results

WALTHAM, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (Avedro) today reported financial results for the quarter ended March 31, 2019. Recent Highlights First quarter...
May 01, 2019 16:05 ET | Source: Avedro, Inc

Avedro Completes Enrollment in Pivotal U.S. Phase 3 Epi-On Corneal Cross-Linking Clinical Trial for Progressive Keratoconus

WALTHAM, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (Avedro), today announced that the company has completed patient enrollment in a pivotal Phase 3 clinical trial to...
April 30, 2019 16:05 ET | Source: Avedro, Inc

Avedro, Inc. to Present at the Bank of America Merrill Lynch Health Care Conference

WALTHAM, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), today announced the company will be participating in the upcoming Bank of America Merrill Lynch Health Care...
April 29, 2019 16:05 ET | Source: Avedro, Inc

Avedro Announces Comprehensive Educational Schedule at ASCRS Annual Meeting

WALTHAM, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (Avedro) today announced the inclusion of a wide range of corneal cross-linking and keratoconus scientific and...